"Live Transplantation in Children Antibody Production against ِE. coli Polypeptide (ECP) by ِDot blotting and ELISA Methods for ECP Assay in Recombinant Drug and Patients Sera "

Abstract

Recombinant DNA technology made it possible to produce biological drugs and pharmaceutical companies produced recombinant human drugs. There have been reports on the formation of antibodies against residual host cell protein. For this reason, it is important to check the patients sera for antibodies which could possibly be induced by recombinant drug it self and/or by contaminating proteins of the host cell. The present report refers to the obtainment of polyspecific antisera directed against Escherichia coli host strain used to produce recombinant human growth hormone. The antisera were obtained by the cascade immunization method. The animals (n=3 rabbits) were initially immunized with E. coli strain. The analysis of the antisera by dot blotting method showed a progressive recognition of the cascade method. These antisera were also used by ELISA methods. Results showed antibodies rising against E. coli polypeptide antigen.